Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulinsShort Communication Published on 2020-09-092022-10-31 Journal: Immunotherapy [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome antibody Cell culture coronavirus CoV COVID-19 COVID-19 pandemic cross-neutralization human coronavirus in vitro Infectivity Intravenous immunoglobulin material MERS-CoV Middle East neutralization neutralization activity Neutralizing activity plaque-forming unit potential therapy produced quantified reduction in reported SARS-CoV SARS-CoV-2 SARS-CoV-2 isolates syndrome tested virus [DOI] 10.2217/imt-2020-0220 PMC 바로가기 [Article Type] Short Communication
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case seriesResearch article Published on 2020-09-012022-10-05 Journal: Virology [Category] SARS, 치료법, [키워드] administration All the patient case sery clinical condition Clinical symptoms COVID-19 COVID-19 patient Deterioration diagnosed discharged dose Effect high mortality High-dose hospital IMPROVE improvement Intravenous immunoglobulin IVIG morbidity O2 Saturation Patient PCR populations Prevalence Prevent prevented progression pulmonary lesion receive reported severe symptom standard treatment the disease therapeutic therapeutic response treated Treatment [DOI] 10.1016/j.virol.2020.05.006 [Article Type] Research article
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 casesCOVID-19와 관련된 길랭-바레 증후군 스펙트럼: 73건의 최신 체계적인 검토Review Published on 2020-08-252022-09-10 Journal: Journal of Neurology [Category] MERS, SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 affected age association Asymptomatic case Asymptomatic cases Autoimmune Case report case reports Case series cerebrospinal fluid classic conducted coronavirus coronavirus disease Coronavirus-2 COVID-19 CSF described distribution distributions Epidemiological study Evidence feature Fisher syndrome Guillain–Barrè syndrome Guillain–Barré syndrome Immune-mediated Immunoglobulin Inflammatory Intravenous immunoglobulin less male male predominance manifestation mechanisms Miller fisher syndrome MOST Most patient Most patients Neuroimmunology NEUROLOGY Older age outbreak outcome Patient Polyneuropathy Polyradiculopathy Prevalence Prognosis rare variant Rare variants reported respiratory SARS-CoV-2 SARS-CoV-2 RNA searched Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus significantly Spectrum subtype suggested syndrome systematic review systemic symptoms tested Treatment variant [DOI] 10.1007/s00415-020-10124-x PMC 바로가기 [Article Type] Review
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemicReview Published on 2020-08-172022-10-29 Journal: Journal of Neurology [Category] COVID-19, MERS, SARS, [키워드] addition Administered Affect airway approach approaches Chloroquine clearance clinicians and researcher condition Coronavirus disease 2019 Course COVID-19 Disease-modifying therapies Diseases disorder drug Evidence Fever First wave form Guidance hospital impair include Infection Intravenous immunoglobulin management manuscript mitochondrial myotonic Neuromuscular disorder centres Neuromuscular disorders non-infected offered Oropharyngeal Other pandemic Patient patients prone positioning provide reduced risk SARS-COV-2 infection SARS-CoV2 infection subgroup of patient Telemedicine the SARS-CoV-2 Treatment treatment regimen Vaccine ventilatory support weakness worsening [DOI] 10.1007/s00415-020-10149-2 PMC 바로가기 [Article Type] Review
Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndromeOriginal Article Published on 2020-08-142022-10-31 Journal: Clinics [Category] COVID-19, MERS, SARS, [키워드] 95%CI abdominal pain abnormality acute respiratory syndrome Admission Adolescent Aspirin association C-reactive protein center children collected Control coronavirus coronavirus disease COVID-19 criteria cross-sectional D-dimer D-dimer level death diagnosed diarrhea ferritin level Frequency gastrointestinal involvement high mortality high mortality rate Hypoxemia Infection Inflammatory intensive care Intravenous immunoglobulin laboratory-confirmed manifestation mechanical ventilation MIS-C Multisystem inflammatory syndrome outcome Outcome, Immunosuppression Oxygen therapy Patient patients pediatric Pediatric patient positive presenting regression analysis renal replacement therapy SARS-CoV-2 serological Shock significantly significantly higher study group syndrome tested the median therapy Univariate analysis vasoactive agent vomiting with COVID-19 [DOI] 10.6061/clinics/2020/e2209 PMC 바로가기 [Article Type] Original Article
Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment A case report6900 Published on 2020-07-242022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] 2019 novel coronavirus active infection acute exacerbation Asymptomatic cardio-respiratory arrest Cardiopulmonary cardiorespiratory arrest Case report clinical history Coronavirus (COVID-19) diagnosed disease Dysphagia elevated hepatitis C high risk hypoxemic immunosuppressive immunosuppressive therapies immunosuppressive therapy Immunosuppressive treatment Inflammatory inflammatory myopathy Intravenous immunoglobulin Patient patients plasma polymerase chain reaction positive receiving rheumatic disease SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA screened suffered tested the patient therapy unique weakness [DOI] 10.1097/MD.0000000000021377 PMC 바로가기 [Article Type] 6900
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) InfectionCase Report Published on 2020-07-182022-10-31 Journal: Case Reports in Pediatrics [Category] COVID-19, [키워드] abdominal pain acute respiratory syndrome Admission advanced respiratory support albumin levels Altered mental status association BNP C-reactive protein cerebrospinal fluid children clinical Clinical practice coronavirus Critically ill CSF died disease dysfunction etiology feature Fever gastrointestinal complaints healthy Infection Inflammatory Inotropes intensive care Intravenous immunoglobulin mechanism Meningitis MIS-C New novel one patient Patient patients pediatric Pediatric patient peptide positive presenting Rash Respiratory failure SARS-CoV-2 SARS-COV-2 infection Shock Steroids syndrome tested the patient Tocilizumab Two patient United States [DOI] 10.1155/2020/8875987 PMC 바로가기 [Article Type] Case Report
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical EffectsImmunology Published on 2020-07-142022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] Asymptomatic Autoimmune blood product caused clinical clinical evidence Concentration confirmed case COVID-19 COVID-19 outbreak develop Effect healthy donor high-dose IVIg highlight Hypothesis IgG Immunoglobulin immunomodulatory effect immunopathological imperative in viral infected individual Inference inflammatory disease Intravenous immunoglobulin IVIG mechanism mechanism of action Mild symptom Mortality novel coronavirus SARS-CoV-2 outbreak pandemic Patient Pneumonia Respiratory failure SARS-CoV-2 severe COVID-19 severe SARS-CoV-2 supportive care therapeutic therapeutic inference therapy Treatment treatment for COVID-19 Viral pneumonia while WHO [DOI] 10.3389/fimmu.2020.01660 PMC 바로가기 [Article Type] Immunology
Immune Thrombocytopenia in a Very Elderly Patient With Covid-19Medicine Published on 2020-07-102022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] acute respiratory syndrome Autoimmune autoimmune disorder bleeding characterized CMV coronavirus Corticosteroid Corticosteroids COVID-19 determine EBV elderly HCV hepatitis C virus HIV Human immunodeficiency virus Immune thrombocytopenia Infection Intravenous immunoglobulin Novel coronavirus infection Patient Platelet reported SARS-COV-2 infection severe adverse events therapeutic strategy thrombocytopenia Trigger triggered very old age virus [DOI] 10.3389/fmed.2020.00404 PMC 바로가기 [Article Type] Medicine
Cytokine Storm in COVID-19: The Current Evidence and Treatment StrategiesImmunology Published on 2020-07-102022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] “cytokine storm” acute respiratory syndrome antimalarial antimalarial agents approach cause caused cells Concentration contribute coronavirus coronavirus disease Corticosteroids COVID-19 COVID-19 patients current cytokine Cytokine storm death effective Evidence IL-6 IL-6 inhibitor immunoregulation indicate induce infiltration Intravenous immunoglobulin lung tissue Lymphocytes Macrophage Mortality outbreak pathogen pathologic feature patients with COVID-19 poor prognosis pro-inflammatory pro-inflammatory cytokines programmed cell death Protein Safe severely ill patient storm Strategy the cytokine storm Tocilizumab Treatment strategies [DOI] 10.3389/fimmu.2020.01708 PMC 바로가기 [Article Type] Immunology